ARDT Stock Overview

Profile

Full Name:

Ardent Health Partners, Inc.

Sector:

Healthcare

Industry:

Medical Care Facilities

Country:

United States

IPO:

Indexes:

Not included

Website:

http://www.ardenthealth.com

Description:

Ardent Health Partners LLC is a healthcare company that operates hospitals and healthcare facilities across the United States. They focus on providing high-quality medical services, improving patient care, and enhancing community health through innovative programs and partnerships. Their mission is to deliver exceptional healthcare experiences.

Key Details

Price

$14.58

Market Cap

$2.08 B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$5.97 B(+10.29% YoY)

Annual EPS

-

PE Ratio

9.56

Annual ROE

-

Annual Debt To Equity

-

Beta

0.38

Events Calendar

Earnings

Next earnings date:

May 30, 2025

Recent quarterly earnings:

Feb 26, 2025

Recent annual earnings:

Feb 26, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 4, 25 RBC Capital
Outperform
Feb 27, 25 Stephens & Co.
Overweight
Jan 21, 25 Morgan Stanley
Overweight
Jan 6, 25 Truist Securities
Buy
Nov 14, 24 RBC Capital
Outperform
Nov 12, 24 Leerink Partners
Outperform
Nov 6, 24 B of A Securities
Neutral
Oct 11, 24 Keybanc
Overweight
Sep 19, 24 Stephens & Co.
Overweight
Aug 16, 24 Truist Securities
Buy

Screeners with ARDT included

Mid cap stocks
US stocks
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
NYSE Companies
Stocks with low beta
Medical Care Facilities industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$14.58
ARDT price is $14.58

Price All-time High

$20.70
ARDT price is currently -29.57% below its historical high of $20.70

Price Analysts Target

$21.00
ARDT price is currently -30.57% lower than the consensus analysts' forecast

Price Most Recent Change

-2.61%
ARDT price was down -2.61% on Mar 7, 2025

Price YTD Change

-10.55%
ARDT price is down -10.55% since January 1st

Price 3-Year Change

-
ARDT price 3-year change is unknown

Market cap

Market Cap

$2.08 B
ARDT market capitalization is $2.08 billion

Market Cap 3-Year Change

-
ARDT market capitalization 3-year change is unknown

Market Cap All-time High

$2.95 B
ARDT market capitalization is currently -29.56% below its historical high of $2.95 billion

Market Cap Sector Rank

82.22%
ARDT market capitalization is higher than 82.22% of companies in Healthcare sector

Technical

Beta

0.38
ARDT beta is 0.38

200-day SMA

$16.79
ARDT price is currently -13.15% below its 200-day simple moving average

14-day RSI

47.14
ARDT 14-day relative strength index is 47.14

30-day Relative Volume

0.88
ARDT 30-day relative volume is 0.88

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$5.97 B
ARDT annual revenue is $5.97 billion

Annual Revenue Analysts Estimate

$6.33 B
ARDT annual revenue is currently -5.75% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+10.29%
ARDT annual revenue is up +10.29% year-on-year

Annual Revenue Sector Rank

92.73%
ARDT annual revenue is higher than 92.73% of companies in Healthcare sector

Profit

Annual Gross Profit

$4.93 B
ARDT annual gross profit is $4.93 billion

Annual Gross Margin

82.68%
ARDT annual gross profit margin is 82.68%

Annual Operating Profit

$405.76 M
ARDT annual operating income is $405.76 million

Annual Operating Margin

6.80%
ARDT annual operating profit margin is 6.80%

Annual Net Income

$210.34 M
ARDT annual net profit is $210.34 million

Annual Net Margin

-
ARDT annual net profit margin value is unknown

EPS

Annual EPS

-
ARDT annual earnings per share value is unknown

Annual EPS Analysts Estimate

$1.88
ARDT annual earnings per share is currently equal to the consensus analysts' forecast

Annual EPS 1-Year Change

-
ARDT annual earnings per share 1-year change is unknown

Annual EPS Sector Rank

-
ARDT annual earnings per share is unknown

ROA & ROE

Annual ROA

4.24%
ARDT annual return on assets is 4.24%

Annual ROE

-
ARDT annual return on equity value is unknown

EBIT & EBITDA

Annual EBIT

$428.64 M
ARDT annual earnings before interest & taxes is $428.64 million

Annual EBITDA

$578.31 M
ARDT annual EBITDA is $578.31 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

9.56
ARDT price to earnings ratio is 9.56

PE Ratio Sector Rank

12.81%
ARDT price to earnings ratio is higher than 12.81% of companies in Healthcare sector

PB Ratio

PB Ratio

1.84
ARDT price to book ratio is 1.84

PB Ratio Sector Rank

57.41%
ARDT price to book ratio is higher than 57.41% of companies in Healthcare sector

PS Ratio

PS Ratio

0.35
ARDT price to sales ratio is 0.35

PS Ratio Sector Rank

10.43%
ARDT price to sales ratio is higher than 10.43% of companies in Healthcare sector

Enterprise value

Enterprise Value

$3.81 B
ARDT enterprise value is $3.81 billion

Enterprise Value Sector Rank

86.14%
ARDT enterprise value is higher than 86.14% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

6.66
ARDT EV/EBITDA is 6.66

EV/EBITDA Sector Rank

78.9%
ARDT EV/EBITDA is higher than 78.9% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.94
ARDT annual current ratio is 1.94

Annual Quick Ratio

1.82
ARDT annual quick ratio is 1.82

Leverage

Annual Debt To Equity

-
ARDT annual debt to equity ratio value is unknown

Annual Interest Coverage Ratio

6.54
ARDT annual interest coverage ratio is 6.54

Risk & Stability

Piotroski F-Score

-
ARDT piotroski f-score value is unknown

Altman Z-Score

2.17
ARDT altman z-score is 2.17

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$4.96 B
ARDT annual total assets is $4.96 billion

Annual Non Current Assets

$3.12 B
ARDT annual long term assets is $3.12 billion

Annual Current Assets

$1.83 B
ARDT annual total current assets is $1.83 billion

Annual Cash & Cash Equivalents

$556.78 M
ARDT annual cash & cash equivalents is $556.78 million

Equity

Annual Book Value

$202.36 M
ARDT annual book value is $202.36 million

Annual Working Capital

$887.33 M
ARDT annual working capital is $887.33 million

Liabilities

Annual Total Liabilities

$3.43 B
ARDT annual total liabilities is $3.43 billion

Annual Total Long Term Liabilities

$2.49 B
ARDT annual total long term liabilities is $2.49 billion

Annual Current Liabilities

$945.42 M
ARDT annual total current liabilities is $945.42 million

Annual Accounts Payable

$401.25 M
ARDT annual accounts payable is $401.25 million

Debt

Annual Total Debt

$2.28 B
ARDT annual total debt is $2.28 billion

Annual Total Debt 1-Year Change

-4.77%
ARDT annual total debt is down -4.77% year-on-year

Annual Long Term Debt

$2.23 B
ARDT annual long term debt is $2.23 billion

Annual Short Term Debt

$9.23 M
ARDT annual short term debt is $9.23 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$5.56 B
ARDT annual total expenses is $5.56 billion

Annual Operating Expenses

$4.53 B
ARDT annual total operating expenses is $4.53 billion

Annual Cost Of Goods Sold

$1.03 B
ARDT annual cost of goods sold is $1.03 billion

Annual SGA

$3.88 B
ARDT annual SGA is $3.88 billion

Annual D&A

$146.29 M
ARDT annual depreciation & amortization is $146.29 million

Annual Interest Expense

$65.58 M
ARDT annual interest expense is $65.58 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$315.03 M
ARDT annual cash flow from operations is $315.03 million

Annual CFO 1-Year Change

+42.1%
ARDT annual cash flow from operations is up +42.1% year-on-year

Annual CFI

-$220.46 M
ARDT annual cash flow from investing activities is -$220.46 million

Annual CFI 1-Year Change

-59.77%
ARDT annual cash flow from investing activities is down -59.77% year-on-year

Annual CFF

$24.64 M
ARDT annual cash flow from financing activities is $24.64 million

Annual CFF 1-Year Change

+124.1%
ARDT annual cash flow from financing activities is up +124.1% year-on-year

Free CashFlow

Annual FCF

$127.52 M
ARDT annual free cash flow is $127.52 million

Annual FCF 1-Year Change

+51.28%
ARDT annual free cash flow is up +51.28% year-on-year

CAPEX

Annual CAPEX

$187.51 M
ARDT annual capital expenditures is $187.51 million

Annual CAPEX 1-Year Change

+36.46%
ARDT annual capital expenditures is up +36.46% year-on-year

Institutional Ownership

Similar stocks

SLNO logo
Soleno Therapeutics (SLNO)
APGE logo
Apogee Therapeutics (APGE)
MIRM logo
Mirum Pharmaceuticals (MIRM)
LIVN logo
LivaNova (LIVN)
ARWR logo
Arrowhead Pharmaceuticals (ARWR)
KYMR logo
Kymera Therapeutics (KYMR)
CNTA logo
Centessa Pharmaceuticals (CNTA)
PACS logo
PACS (PACS)
AZTA logo
Azenta (AZTA)

FAQ

  • What is the ticker symbol for Ardent Health Partners LLC?
  • Does Ardent Health Partners LLC pay dividends?
  • What sector is Ardent Health Partners LLC in?
  • What industry is Ardent Health Partners LLC in?
  • What country is Ardent Health Partners LLC based in?
  • Is Ardent Health Partners LLC in the S&P 500?
  • Is Ardent Health Partners LLC in the NASDAQ 100?
  • Is Ardent Health Partners LLC in the Dow Jones?
  • When was Ardent Health Partners LLC's last earnings report?
  • When does Ardent Health Partners LLC report earnings?
  • Should I buy Ardent Health Partners LLC stock now?

What is the ticker symbol for Ardent Health Partners LLC?

The ticker symbol for Ardent Health Partners LLC is NYSE:ARDT

Does Ardent Health Partners LLC pay dividends?

No, Ardent Health Partners LLC does not pay dividends

What sector is Ardent Health Partners LLC in?

Ardent Health Partners LLC is in the Healthcare sector

What industry is Ardent Health Partners LLC in?

Ardent Health Partners LLC is in the Medical Care Facilities industry

What country is Ardent Health Partners LLC based in?

Ardent Health Partners LLC is headquartered in United States

Is Ardent Health Partners LLC in the S&P 500?

No, Ardent Health Partners LLC is not included in the S&P 500 index

Is Ardent Health Partners LLC in the NASDAQ 100?

No, Ardent Health Partners LLC is not included in the NASDAQ 100 index

Is Ardent Health Partners LLC in the Dow Jones?

No, Ardent Health Partners LLC is not included in the Dow Jones index

When was Ardent Health Partners LLC's last earnings report?

Ardent Health Partners LLC's most recent earnings report was on Feb 26, 2025

When does Ardent Health Partners LLC report earnings?

The next expected earnings date for Ardent Health Partners LLC is May 30, 2025

Should I buy Ardent Health Partners LLC stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions